Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A critical question for HIV vaccine development: which antibodies to induce?

Science (New York, N.Y.) - 11 Jul 2014

Zolla-Pazner Susan

Abstract excerpt

A vaccine against HIV-1 must prevent infection against genetically diverse virus strains. Two approaches are currently being pursued to elicit antibody-mediated protection: vaccines that induce potent and broadly reactive neutralizing antibodies (bnAbs) or vaccines that induce "conventional antibodies," which are less potent and broadly neutralizing in comparison. Although bnAbs may provide the greatest level of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Neutralizing
Share to Antibody Formation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase III as Topic

Share to Drug Design

Share to HIV Antibodies

Share to HIV Infections

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 25013066
DOI: 10.1126/science.1256526
PMCID: PMC4481191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A critical question for HIV vaccine development: which antibodies to induce?PMID 25013066Read ↗

Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.Semantic proximity Read ↗

Harnessing the protective potential of HIV-1 neutralizing antibodiesSemantic proximity Read ↗

Catch Me If You Can--The Race Between HIV and Neutralizing Antibodies.Semantic proximity Read ↗

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Semantic proximity Read ↗

<scp>HIV</scp>‐1 neutralizing antibodies: understanding nature's pathwaysSemantic proximity Read ↗

HIV-1 vaccine immunogen design strategiesSemantic proximity Read ↗

Broadly neutralizing antibodies against HIV-1: Templates for a vaccineSemantic proximity Read ↗

Virological features associated with the development of broadly neutralizing antibodies to HIV-1.Semantic proximity Read ↗

Design of immunogens to elicit broadly neutralizing antibodies against HIV targeting the CD4 binding site.Semantic proximity Read ↗

Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development.Semantic proximity Read ↗

Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopesSemantic proximity Read ↗

Can we use structural knowledge to design a protective vaccine against HIV-1?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.